TL;DR — Creatine and Epilepsy
The relationship between creatine and epilepsy operates on two levels. First, in rare creatine deficiency syndromes (GAMT and AGAT deficiency), severely reduced brain creatine levels cause intractable seizures, and creatine supplementation can be dramatically effective — reducing or eliminating seizures entirely. Second, in common epilepsy, the brain energy connection is more nuanced: seizures are enormously energy-demanding events, and inadequate phosphocreatine reserves may both lower seizure thresholds and worsen post-seizure damage. Animal studies suggest creatine has anticonvulsant properties, but clinical translation to common epilepsy remains limited. For the estimated 200,000+ Malaysians living with epilepsy, this research represents an emerging area of interest that warrants discussion with treating neurologists, particularly as our understanding of brain energy metabolism in seizure disorders continues to evolve.
Creatine Deficiency Syndromes and Seizures
The clearest evidence for creatine’s role in seizures comes from genetic creatine deficiency disorders:
GAMT deficiency. Guanidinoacetate methyltransferase (GAMT) deficiency prevents the final step of creatine synthesis. Affected individuals have severely depleted brain creatine, leading to intractable epilepsy, intellectual disability, and movement disorders. Creatine supplementation (400-800 mg/kg/day) can dramatically improve or resolve seizures in these patients.
AGAT deficiency. Arginine:glycine amidino-transferase (AGAT) deficiency blocks the first step of creatine synthesis. Similar to GAMT deficiency, this results in brain creatine depletion and seizures. Creatine supplementation is highly effective for AGAT-deficient patients, often normalizing brain creatine on MRS imaging.
CT1 deficiency. Creatine transporter (SLC6A8) deficiency prevents creatine from entering the brain even when blood levels are normal. Unfortunately, creatine supplementation is less effective for CT1 deficiency because the defective transporter limits brain uptake. This condition highlights the importance of the creatine transport system (S et al., 2007) .
Clinical implications. These genetic conditions provide direct evidence that brain creatine is essential for neuronal stability and seizure prevention. The dramatic response to supplementation in GAMT and AGAT deficiency demonstrates a causal relationship between brain creatine levels and seizure susceptibility.
Brain Energy and Seizure Mechanisms
The energy metabolism connection to common epilepsy is increasingly recognized:
Seizures as energy crises. A single generalized tonic-clonic seizure can increase brain glucose consumption by 200-300%. The intense, synchronized neuronal firing during seizures creates enormous ATP demand that can exhaust phosphocreatine reserves within seconds.
Seizure threshold and energy. Neurons with adequate energy reserves can maintain proper ion gradients and inhibitory signaling. When phosphocreatine levels are low, the energy margin narrows, potentially lowering the threshold for abnormal electrical activity.
Post-ictal energy depletion. The cognitive impairment and fatigue following seizures (post-ictal state) correlate with depleted brain energy metabolites. Faster phosphocreatine recovery could theoretically reduce post-ictal duration and severity (RB et al., 2017) .
Mitochondrial epilepsies. A subset of epilepsies involves mitochondrial dysfunction as a primary mechanism. In these conditions, impaired ATP production directly contributes to seizure susceptibility, making the phosphocreatine buffer system particularly relevant.
Preclinical Evidence for Anticonvulsant Effects
Animal studies suggest creatine may have anticonvulsant properties:
Chemical seizure models. In rodent models using pentylenetetrazol (PTZ) and other seizure-inducing agents, creatine pretreatment has shown dose-dependent anticonvulsant effects, increasing seizure latency and reducing seizure severity.
Mechanism studies. The anticonvulsant effect appears to involve multiple mechanisms: direct energy buffering, modulation of glutamate (excitatory) neurotransmission, support of GABAergic (inhibitory) signaling, and stabilization of neuronal membrane potential.
Neuroprotection after seizures. Beyond preventing seizures, creatine supplementation in animal models has reduced seizure-induced neuronal damage, suggesting a neuroprotective role that could limit the progressive brain injury associated with repeated seizures.
Clinical Evidence in Common Epilepsy
Clinical data for creatine in common epilepsy remains limited:
Case reports. Scattered case reports describe individual patients with epilepsy who experienced reduced seizure frequency after starting creatine supplementation, though these cannot establish causation.
No large clinical trials. To date, no large randomized controlled trials have examined creatine supplementation specifically for common epilepsy. The existing evidence is primarily preclinical or derived from creatine deficiency syndromes (H et al., 2021) .
Exercise and epilepsy. Regular exercise reduces seizure frequency in many epilepsy patients, and creatine supplementation enhances exercise performance. This indirect pathway may provide some benefit, though the effect size for seizure reduction through this mechanism is uncertain.
Malaysian Epilepsy Context
Epilepsy affects an estimated 1-2% of the Malaysian population:
- The Malaysian Society of Neurosciences coordinates epilepsy care and awareness across the country
- Major epilepsy centres operate in Kuala Lumpur General Hospital, University Malaya Medical Centre, and Hospital Sultanah Aminah
- Genetic testing for creatine deficiency syndromes is available through specialized centres, though awareness among clinicians may be limited
- For Malaysian families with unexplained epilepsy (especially with intellectual disability), screening for creatine deficiency syndromes may be worth discussing with neurologists
Important Safety Considerations
For epilepsy patients considering creatine:
- Always consult your neurologist before starting creatine supplementation
- Do not reduce or stop anti-epileptic medications — creatine is not a substitute for prescribed seizure medications
- No known drug interactions with common anti-epileptic drugs, but disclosure to your medical team is essential
- Standard dosing of 3-5g creatine monohydrate daily is appropriate; there is no evidence that higher doses provide additional benefit for seizure reduction
- Monitor carefully and report any changes in seizure frequency or pattern to your neurologist
- Genetic testing may be appropriate if seizures are accompanied by intellectual disability and movement disorders
Key Takeaways
Creatine has a clear and direct role in seizure prevention in creatine deficiency syndromes, where supplementation can be life-changing. For common epilepsy, the energy metabolism connection is scientifically sound but clinically unproven. Animal studies showing anticonvulsant effects are encouraging but have not yet translated to clinical recommendations. Malaysian epilepsy patients should discuss creatine supplementation with their neurologist, particularly those with treatment-resistant epilepsy or suspected metabolic components to their condition.